semaglutide cardiovascular benefits GLP-1 receptor agonists improve health in type 2 diabetes GLP-1 agonists like Ozempic may

Tirzepatide (GIP / GLP-1) HSA/FSA Eligible Semaglutide targets one hormone pathway

This has led to interest in whether GLP-1 agonists might have neuroprotective or cognitive effects beyond their metabolic actions

Unlike earlier GLP-1 agonists like semaglutide (Ozempic, Wegovy) that target only one receptor, Retatrutide activates three distinct pathways simultaneously

The data confirms that for Type 2 diabetes patients on basal insulin, CGM technology isn't just a "nice-to-have"it's a critical tool for improving HbA1c and increasing Time in Range (TIR)

GLP-1 receptor activation The GLP-1 component works similarly to semaglutide and tirzepatide

Ozempic and Wegovy are registered trademarks of their respective owners